Reinhart Charles A. III
- SEC CIK
- 0001470871
No open-market purchases or sales filed in the past year.
Current role at each company
- PCRX Pacira BioSciences, Inc.Chief Financial Officeras of Jun 13, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Reinhart Charles A. III as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2023 (view filing) | Jun 6-7 | 1 day | Reinhart Charles A. IIIChief Financial Officer | SSale | −2.61K | $38.40 | −$100.1K | −7.2%33.6K after | 2 lots |
| Jun 8, 2022 (view filing) | Jun 6 | 2 days | Reinhart Charles A. IIIChief Financial Officer | SSale | −2.52K | $61.37 | −$154.4K | −8.2%28.3K after |